Bivalirudin or Heparin Treatment During Transcatheter Valve Interventions: Where are we Now?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|13|1911-1917

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.13, 2016-04, pp. : 1911-1917

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bivalirudin to replace heparin in coronary interventions?

By  

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Adjuvant Treatment in Non-Small Cell Lung Cancer: Where Are We Now?

By Juergens Rosalyn A.   Brahmer Julie R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 6, 2006-07 ,pp. : 595-600

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Intermediate care – where are we now?

By Harari Danielle  

Clinical Medicine, Vol. 2, Iss. 5, 2002-09 ,pp. : 477-479

Royal College Of Physicians

Access to resources Recommend Favorite

Discovery and ADMET: Where Are We Now

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 4, 2011-02 ,pp. : 467-481

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase 4 Inhibitors and the Treatment of Asthma: Where Are We Now and Where Do We Go from Here?

By Giembycz M.A.  

Drugs, Vol. 59, Iss. 2, 2000-02 ,pp. : 193-212

Adis International

Access to resources Recommend Favorite